Internal Medicine · South Ozone Park, NY
NPI
1124087713
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
13405 Rockaway Blvd
South Ozone Park, NY, 11420
Phone (718) 323-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
912 services
Medicare patients, 2024
100
Average age 70
Drug cost, 2024
$8.6M
54,182 prescriptions
Company payments, 2025
$1,975
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fausto A Gonzalez was code 99213 (office e&m - established), 173 times for 76 patients. In total Fausto A Gonzalez billed 912 services in 31 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 173 | 76 | $75.13 | $13K |
| 99212 Office E&M - Established | Office | 130 | 47 | $47.84 | $6,219 |
| 99458 E&M - Miscellaneous | Office | 123 | 14 | $28.94 | $3,559 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 107 | 43 | $102.33 | $11K |
| 36415 Venipuncture Blood Collection | Office | 98 | 57 | $8.65 | $848 |
| 99457 E&M - Miscellaneous | Office | 62 | 14 | $35.43 | $2,197 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 52 | 18 | $54.56 | $2,837 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 27 | 27 | $144.53 | $3,902 |
By year: 2022 $50K for 899 services; 2023 $48K for 893 services; 2024 $51K for 912 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 98 | 57 | $8.65 | $848 |
Medicare prescription drug claims, 2024
In 2024, the drug Fausto A Gonzalez prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,015 prescriptions and refills. In total Fausto A Gonzalez wrote 54,182 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,015 | 2,615 | 340 | $17K |
| Diclofenac Sodium Generic | 2,002 | 2,171 | 368 | $608K |
| Omeprazole Generic | 1,874 | 2,285 | 293 | $15K |
| Metformin Hcl Generic | 1,768 | 2,238 | 266 | $21K |
| Amlodipine Besylate Generic | 1,444 | 1,944 | 237 | $8,498 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,128 | 1,265 | 174 | $34K |
| Meloxicam Generic | 962 | 1,095 | 185 | $5,715 |
| Meclizine Hcl Generic | 883 | 1,026 | 147 | $6,994 |
| Levothyroxine Sodium Generic | 881 | 1,147 | 131 | $6,390 |
| Gabapentin Generic | 878 | 982 | 153 | $4,461 |
| Lisinopril Generic | 862 | 1,160 | 138 | $5,394 |
| Simvastatin Generic | 833 | 1,205 | 137 | $4,796 |
| Hydrochlorothiazide Generic | 824 | 1,046 | 139 | $1,623 |
| Ibuprofen Generic | 803 | 817 | 129 | $6,360 |
| Ozempic Semaglutide | 791 | 818 | 104 | $749K |
Brand drugs: 10,274 claims; generic drugs: 42,915 claims; opioid claims: 572.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fausto A Gonzalez $1,975 ($1,975 in general payments such as food, travel and fees) from 24 companies. The largest payer was Novo Nordisk Inc with $356.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 10 | $356 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $217 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 13 | $211 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $159 |
| Pfizer Inc. PFE | 4 | $119 |
| Kowa Pharmaceuticals America, Inc. | 5 | $102 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81.33 |
| Abbvie Inc. ABBV | 4 | $78.44 |
| Genzyme Corporation SNY | 4 | $68.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.